BindingDB logo
myBDB logout

null

SMILES: OC(=O)c1nc(ccc1-c1cnn(Cc2cccc(c2)-c2ccccc2)c1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1

InChI Key: InChIKey=TVRPYMRYYVUXHU-UHFFFAOYSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 209112   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Bcl-2-like protein 1


(Homo sapiens (Human))
BDBM209112
PNG
(US9266877, 58)
Show SMILES OC(=O)c1nc(ccc1-c1cnn(Cc2cccc(c2)-c2ccccc2)c1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1
Show InChI InChI=1S/C39H30N6O3S/c46-37(43-39-41-33-14-4-5-15-34(33)49-39)31-13-7-11-27-18-19-44(24-32(27)31)35-17-16-30(36(42-35)38(47)48)29-21-40-45(23-29)22-25-8-6-12-28(20-25)26-9-2-1-3-10-26/h1-17,20-21,23H,18-19,22,24H2,(H,47,48)(H,41,43,46)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
174 -9.21n/an/an/an/an/an/a25



ABBVIE INC.

US Patent


Assay Description
The measurement of competition of compounds of Formula (I) with F-Bak for a Bcl-2 family protein (Bcl-xL) binding site using a Time Resolved Fluoresc...


US Patent US9266877 (2016)


BindingDB Entry DOI: 10.7270/Q2H41Q7V
More data for this
Ligand-Target Pair
Bcl-2-like protein 1


(Mus musculus (Mouse))
BDBM209112
PNG
(US9266877, 58)
Show SMILES OC(=O)c1nc(ccc1-c1cnn(Cc2cccc(c2)-c2ccccc2)c1)N1CCc2cccc(C(=O)Nc3nc4ccccc4s3)c2C1
Show InChI InChI=1S/C39H30N6O3S/c46-37(43-39-41-33-14-4-5-15-34(33)49-39)31-13-7-11-27-18-19-44(24-32(27)31)35-17-16-30(36(42-35)38(47)48)29-21-40-45(23-29)22-25-8-6-12-28(20-25)26-9-2-1-3-10-26/h1-17,20-21,23H,18-19,22,24H2,(H,47,48)(H,41,43,46)
PDB

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a>1.00E+3n/an/an/an/a



ABBVIE INC.

US Patent


Assay Description
The efficacy of the compounds of Formula (I) can also be determined in cell-based killing assays using a variety of cell lines and mouse tumor models...


US Patent US9266877 (2016)


BindingDB Entry DOI: 10.7270/Q2H41Q7V
More data for this
Ligand-Target Pair